Tci Wealth Advisors, Inc. Charles River Laboratories International, Inc. Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$197.11 - $250.07 $394 - $500	2 Added 40.0%	7 $1,000
Q3 2022 Nov 08, 2022	SELL	$182.44 - $250.54 $729 - $1,002	-4 Reduced 44.44%	5 $1,000
Q2 2022 Jul 19, 2022	BUY	$204.13 - $302.4 $1,224 - $1,814	6 Added 200.0%	9 $2,000
Q1 2022 Apr 29, 2022	BUY	$255.51 - $362.11 $766 - $1,086	3 New	3 $1,000
Q1 2020 Apr 14, 2020	SELL	$98.9 - $178.34 $2,373 - $4,280	-24 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$126.05 - $152.76 $3,025 - $3,666	24 New	24 $4,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.